The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.
Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...
An assisted living center for people with dementia has been fined $6,000 for a serious medication error that resulted in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results